Respicardia's remedand#275;(R) System Receives FDA Approval

Breakthrough Treatment of Moderate to Severe Central Sleep Apnea in Adult Patients Now Available MINNETONKA, Minn., Oct. 10, 2017 -- (Healthcare Sales & Marketing Network) -- Respicardia, Inc., a private medical technology company, announced today that... Devices, Neurology, FDA Respicardia, remedē System, neurostimulation, sleep apnea

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043059

Source: HSMN NewsFeed - October 10, 2017 Category: Pharmaceuticals Source Type: news